Short answer
Tevogen Bio Holdings Inc. (TVGN) filed an 8-K current report with the SEC on September 30, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Tevogen regained compliance with Nasdaq’s $50 million minimum market value requirement under Rule 5450(b)(2)(A).
Tevogen Bio Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Tevogen regained compliance with Nasdaq’s $50 million minimum market value requirement under Rule 5450(b)(2)(A)
- Continued listing on The Nasdaq Global Market preserved, reducing delisting risk for TVGN and TVGNW holders
- Nasdaq compliance matter closed on September 29, 2026
- Company press release issued September 30, 2026; details furnished as Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Nasdaq Global Market compliance restored under the $50 million minimum market value requirement
- Minimum market value of publicly held shares requirement also satisfied
- Both previously disclosed Nasdaq compliance matters closed, reducing delisting risk for TVGN and TVGNW holders
- Compliance confirmation dated September 29, 2026; announcement issued September 30, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tevogen Bio Holdings Inc. 8-K filings
Get the next TVGN 8-K as it lands
Follow TVGN for push alerts, or ask the research agent what this filing means.